| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.3 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.3 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.4 |